On December 30, the Shanghai Pharmaceutical Centralized Bidding and Procurement Service Administration issued a notice clarifying that the national organization will begin the second procurement year on January 1, 2026, and that a new 12-month procurement cycle will begin to ensure the continuity of patients' medication use and maintain price dividends.

On December 30, the Shanghai Pharmaceutical Centralized Bidding and Procurement Service Administration issued a notice clarifying that the national organization will begin the second procurement year on January 1, 2026, and that a new 12-month procurement cycle will begin to ensure the continuity of patients' medication use and maintain price dividends.